| Literature DB >> 25843893 |
S E Cremer1, S G Moesgaard2, C E Rasmussen2, N E Zois3, T Falk4, M J Reimann1, S Cirera5, H Aupperle6, M A Oyama7, L H Olsen8.
Abstract
Canine Myxomatous mitral valve disease (MMVD) is an age-related disease. Serotonin (5-HT) is implicated in the pathogenesis as locally-produced or platelet-derived. Involvement of the 5-HT2A receptor (R) and 5-HT2BR in the induction of myxomatous-mediating valvular myofibroblasts (MF) has been suggested. In an age-matched population of dogs with non-clinical and clinical MMVD, the objectives were to investigate (1) gene expression of 5-HT2AR and 5-HT2BR, (2) protein expression and spatial relationship of 5-HT2AR, 5-HT2BR and MF in the mitral valve (MV) and the cardiac anterior papillary muscle (AP) and (3) serum 5-HT concentrations. Gene expression of 5-HT2BR was significantly higher in MV and AP among dogs with clinical MMVD. This was not found for 5-HT2BR protein expression, though association of 5-HT2BR with myxomatous pathology and co-localization of 5-HT2BR and MF in MV and AP support a functional relationship, perhaps perpetuation of clinical MMVD. 5-HT2AR-expression and serum 5-HT showed no differences between groups.Entities:
Keywords: 5-HT(2A)R; 5-HT(2B)R; CKCS; Dog; Heart valve disease; MMVD
Mesh:
Substances:
Year: 2015 PMID: 25843893 DOI: 10.1016/j.rvsc.2015.03.020
Source DB: PubMed Journal: Res Vet Sci ISSN: 0034-5288 Impact factor: 2.534